| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40032-999-05 | 40032-999 | HUMAN PRESCRIPTION DRUG | cevimeline hydrochloride | cevimeline hydrochloride | CAPSULE | ORAL | 20161230 | N/A | ANDA | ANDA204746 | Novel Laboratories, Inc. | CEVIMELINE HYDROCHLORIDE | 30 mg/1 | 500 CAPSULE in 1 BOTTLE (40032-999-05) |
| 40032-999-03 | 40032-999 | HUMAN PRESCRIPTION DRUG | cevimeline hydrochloride | cevimeline hydrochloride | CAPSULE | ORAL | 20161230 | N/A | ANDA | ANDA204746 | Novel Laboratories, Inc. | CEVIMELINE HYDROCHLORIDE | 30 mg/1 | 30 CAPSULE in 1 BOTTLE (40032-999-03) |
| 40032-999-01 | 40032-999 | HUMAN PRESCRIPTION DRUG | cevimeline hydrochloride | cevimeline hydrochloride | CAPSULE | ORAL | 20161230 | N/A | ANDA | ANDA204746 | Novel Laboratories, Inc. | CEVIMELINE HYDROCHLORIDE | 30 mg/1 | 100 CAPSULE in 1 BOTTLE (40032-999-01) |